ALXO - ALX Oncology GAAP EPS of -$0.87 misses by $0.08 November, 08 2022 05:06 PM ALX Oncology Holdings Inc. ALX Oncology press release ( NASDAQ: ALXO ): Q3 GAAP EPS of -$0.87 misses by $0.08 . Cash, cash equivalents and investments were $293.1 million as of September 30, 2022. For further details see: ALX Oncology GAAP EPS of -$0.87 misses by $0.08